The largest database of trusted experimental protocols

Paxgene blood rna kit ivd

Manufactured by Qiagen
Sourced in Germany, United States

The PAXgene Blood RNA Kit IVD is a laboratory product designed for the stabilization, storage, and purification of RNA from whole blood samples. The kit helps preserve the RNA profile of the sample from the time of collection through the RNA isolation process.

Automatically generated - may contain errors

20 protocols using paxgene blood rna kit ivd

1

RNA-Sequencing of Whole Blood Transcriptome

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-blood extracts of the Discovery Cohort were total RNA-sequenced. PAXgene Blood RNA Kit IVD (#762174, Qiagen) and Tempus™ Spin RNA Isolation Kit (#4380204, Thermo Fisher Scientific) were used for RNA isolation. Library construction was performed using NEBNext® rRNA Depletion Kit v2 (#E7400, New England Biolabs) and NEBNext® Ultra II Directional RNA Library Prep with Sample Purification Beads Kit (#E7765 New England Biolabs). Library quality was assessed using a 2100 Bioanalyzer (Agilent), and a Qubit 4 Fluorometer with dsDNA HS assay kit (#Q32854, Thermo Fisher Scientific) was used for quantitation of libraries. 100-bp paired-end sequencing was performed on an Illumina Nova-Seq 6000 System.
+ Open protocol
+ Expand
2

RNA Extraction and Reverse Transcription from Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was collected from all participants by venipuncture of a forearm vein into PAXgene Blood RNA tubes (Qiagen, California, USA), which were stored at −20°C until processed. Total RNA was extracted using the PAXgene Blood RNA Kit IVD according to the manufacturer’s instructions (Qiagen, California, USA). All samples were eluted in 80 µl of elution buffer and stored at −80°C until further analysis. RNA yield and quality were assessed using an Agilent Model 2100 Bioanalyzer (Agilent Technologies, California, USA) and a DropSense 16 spectrophotometer (TRINEAN, Belgium). All samples had 260/280 > 2.0 and RIN > 7.0.
Reverse transcription was performed using the High-Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Applied Biosystems, California, USA), according to the manufacturer’s specifications. Briefly, for each sample, 100 ng of RNA was added to 2 μl of random and oligo (dT) primers in a final reaction of 20 μl. These reaction tubes were then placed in the GeneAmp® PCR Systems 2700 (Applied Biosystems, California, USA) thermocycler at 25°C for 10 min, 37°C for 120 min, and 85°C for 5 min to inactivate the reverse transcriptase enzyme. The cDNA samples were then stored at −20°C until analyzed.
+ Open protocol
+ Expand
3

RT-PCR Analysis of Blood mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from blood samples using the PAXgene Blood RNA Kit IVD (Qiagen). Polyadenylated mRNA was reverse transcribed into cDNA using the SuperScript IV Reverse Transcriptase Kit (ThermoFisher) with oligo d(T) primers. Primer sequences for the PCR on the synthesized cDNA are listed in the S4 Table. The products were analyzed on a Fragment Analyzer capillary gel electrophoresis instrument (Advanced Analytical). The sequence of the obtained RT-PCR products was confirmed by Sanger sequencing as described above.
+ Open protocol
+ Expand
4

RNA Extraction from Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from frozen PAXgene blood RNA tube of psoriasis patients and control subjects. Total RNA was extracted using the PAXgene Blood RNA Kit IVD (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. To ensure complete DNA removal, on-column DNase digestion was performed and RNA was eluted in 15–20 μl RNase-free water.
+ Open protocol
+ Expand
5

Transcriptome Analysis of Clinical Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transcriptome analysis was performed using RT2 Profiler PCR Arrays technology (Qiagen, USA) to allow simultaneous multi-gene expression profiling in clinical samples. Blood samples were collected at screening Visit 1 (baseline) and at Visit 8. Total RNA purification was measured on an automated QIAcube system (Qiagen) using PAXgene Blood RNA kit IVD (Qiagen, Frederick, USA). RNA quality and concentration was determined by using a nanodrop spectrophotometer to measure the concentration and OD260/280 ratio of the samples. An OD260/280 ratio of between 1.8 to 2.0 and RNA concentration >40 μg/mL were used for high quality isolated RNA. RNA integrity was assessed using an RNA ScreenTape on Agilent TapeStation 2200 (Agilent Technologies).
The first strand cDNA synthesis was performed using QIAGEN RT2 First Strand Kit (Qiagen, USA). RT2 Profiler PCR Array gene expression analysis was performed by RT2 Profiler PCR Array Service (Qiagen, Frederick, USA) using RT2 SYBR® Green qPCR Mastermix and Custom RT2 Profiler PCR Array (Qiagen, CLAH24893).
+ Open protocol
+ Expand
6

RT-PCR Sequencing for RNA Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RT-PCR sequencing was performed as previously described [28 (link)]. Briefly, we isolated RNA using the PAXgene Blood RNA Kit IVD (Qiagen, Hilden, Germany) and performed RT-PCR using the OneStep RT-PCR Kit (Qiagen). Primer sequences were as follows: Forward primer: 5′-CCTGGCGAATATGCTGTTCACATC-3′ and reverse primer: 5′-CGGGGTGTATGAGCATGCATATGT-3′. Amplicons were extracted from the agarose gel using the QIAquick Gel Extraction Kit (Qiagen) and were subsequently sequenced. Sequence traces were assembled, aligned and analysed with the Seqman software (DNASTAR Lasergene, Madison, WI, USA).
+ Open protocol
+ Expand
7

RNA Extraction and RT-PCR Analysis of Genetic Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from the patient’s LCLs and peripheral blood using the High Pure RNA Isolation Kit (Roche, Basel, CH) and PAXgene Blood RNA Kit IVD (QIAGEN, Hilden, DE), respectively, according to the manufacturer’s instructions. cDNA was synthetized using the Transcriptor First Strand cDNA Synthesis Kit (Roche, Basel, CH), and RT-PCRs were prepared with KAPA2G Fast HotStart (KAPA Biosystems, Wilmington, MA). To verify the deletion from exons 11 to 14, RT-PCR primers 9F 5′-TTG​ATG​TAC​TGC​AGA​GAA​TGC-3′ and 16R 5′-GTG​TCT​TGG​CCA​ATG​AGA​TG-3’ were used. To assess the c.2778 + 83C>G effect, RT-PCR primers 27F 5′-AGC​TGC​TTA​TCT​CCA​GGC​C-3, 28R_+83 5′-CAA​ACC​CTA​GAC​TCA​GGA​CG-3,′ and 30R 5′-GGA​AAT​CCA​TCA​GTG​CGT​TG-3′3′ were designed within the predicted intronic retention and used in Savino et al. (1997) (link) to characterize the variant. RT-PCR amplicon extraction from 3% agarose gel was performed using the QIAquick Gel Extraction Kit (QIAGEN, Hilden, DE) in line with the manufacturer’s instructions. To increase the performance and purify the extraction, the products obtained were further subjected to classical PCR with the same primer pair used for RT-PCR. All RT-PCR amplicons were purified and sequenced, as reported previously.
+ Open protocol
+ Expand
8

RNA Extraction and RT-PCR Analysis of Genetic Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from the patient’s LCLs and peripheral blood using the High Pure RNA Isolation Kit (Roche, Basel, CH) and PAXgene Blood RNA Kit IVD (QIAGEN, Hilden, DE), respectively, according to the manufacturer’s instructions. cDNA was synthetized using the Transcriptor First Strand cDNA Synthesis Kit (Roche, Basel, CH), and RT-PCRs were prepared with KAPA2G Fast HotStart (KAPA Biosystems, Wilmington, MA). To verify the deletion from exons 11 to 14, RT-PCR primers 9F 5′-TTG​ATG​TAC​TGC​AGA​GAA​TGC-3′ and 16R 5′-GTG​TCT​TGG​CCA​ATG​AGA​TG-3’ were used. To assess the c.2778 + 83C>G effect, RT-PCR primers 27F 5′-AGC​TGC​TTA​TCT​CCA​GGC​C-3, 28R_+83 5′-CAA​ACC​CTA​GAC​TCA​GGA​CG-3,′ and 30R 5′-GGA​AAT​CCA​TCA​GTG​CGT​TG-3′3′ were designed within the predicted intronic retention and used in Savino et al. (1997) (link) to characterize the variant. RT-PCR amplicon extraction from 3% agarose gel was performed using the QIAquick Gel Extraction Kit (QIAGEN, Hilden, DE) in line with the manufacturer’s instructions. To increase the performance and purify the extraction, the products obtained were further subjected to classical PCR with the same primer pair used for RT-PCR. All RT-PCR amplicons were purified and sequenced, as reported previously.
+ Open protocol
+ Expand
9

Comprehensive RNA Sequencing of Primate Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA for 499 samples was extracted using the MagMAX for Stabilized Blood Tubes RNA Isolation Kits (Thermo Fisher), and RNA from 48 samples was extracted using the PAXgene Blood RNA Kit IVD (Qiagen) following the standard protocols for each procedure. RQN was quantified using AATI Fragment Analyzer. RNA sequencing libraries were prepared using 50 ng of total RNA and following a recently developed 3′-biased protocol, TM3′SEq. (74 (link)). Libraries were amplified with 16 PCR cycles. All other procedures followed the published protocol or manufacturer recommendations. Libraries were combined in equimolar quantities and sequenced on an Illumina NovaSeq S2 flowcell (R1 was 25 bp and R2 was 80 bp to capture the complementary DNA [cDNA] transcript) to an average read depth of 3.5 million reads per sample. We mapped cDNA reads to the M. mulatta reference assembly Mmul_10 using kallisto (75 (link)) (average mapping rate = 71.1%).
+ Open protocol
+ Expand
10

RNA-seq Library Preparation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA extraction was performed with a PAXgene Blood RNA kit IVD (QIAGEN, Hilden, Germany). The RNA-seq library was prepared with a TruSeq Stranded mRNA Sample Preparation Kit (Illumina, San Diego, CA, USA). The messenger RNA libraries were sequenced by paired-end 100 cycles on the HiSeq 2500 (Illumina). Low-quality bases in the raw reads were filtered out by FastQC ver 0.11.5 [16 ] and potentially existing sequencing adapters were trimmed with Skewer ver 0.2.2 [17 (link)]. The high-quality reads were mapped to the human reference genome hg19 (downloaded from UCSC genome browser, https://genome.ucsc.edu) by STAR ver 2.6 [18 (link)]. The gene expression level was quantified based on the aligned reads by Cufflinks package ver 2.2.1 [19 (link)]. The gene annotation of the reference genome was used as gene models and the expression values were calculated in Fragments Per Kilobase of transcript per Million fragments mapped (FPKM) unit.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!